Latest Infant Nutrition Market News

Australian Dairy Nutritionals reported a 47% reduction in net loss for FY26, driven by a 66% revenue jump in its nutritional powders segment, which now makes up 70% of total revenue.

Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.

Bubs Australia Limited announces it expects to recover A$825,000 from Willis Trading Limited’s secured creditor following arbitration proceedings, while no further recoveries are anticipated from related parties.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Australian Dairy Nutritionals reported a 66% year-on-year revenue increase in Q1 FY26, driven by strong nutritional powder sales and expanded distribution in China, while improving cash flow and production capacity.

Bubs Australia has triumphed in a long-standing legal dispute, winning $26.5 million in arbitration awards against Alpha Group subsidiaries Alice Trading and Willis Trading. The company now faces the challenge of recovering the awarded sums.